About this trial
The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs).
Participants will:
* undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras
Eligibility criteria
Qualifiers
Participants 18 years and older with a clinical and/ or genetic diagnosis of IRD recruited either from the clinic and/or the Inherited Ocular Disease Registry to participate in this trial
Participants that are willing to participate as evidenced by signing the written informed consent
Disqualifiers
Presence of ocular conditions other than an IRD which may affect the quality of ocular imaging including but not limited to advanced cataracts, corneal disorders, nystagmus, vitreous hemorrhage, or poor dilation
Presence of ocular conditions other than an IRD which may affect interpretation of retinal imagining including but not limited to epiretinal membrane, choroidal neovascular membrane, or macular scarring
Patients with advanced IRDs who are unable to fixate for imaging
Patients unable to tolerate ocular imaging
Trial design
Treatments tested in this trial
- Spectralis FAF imaging
- Optos imaging
- Clarus imaging